Image (7f66fad6 E7f7 40aa A751 Bf6e681ac721 01)
Liothyronine Sodium Tablet
Product Images NDC 68382-583
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 68382-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label (7f66fad6 E7f7 40aa A751 Bf6e681ac721 02)
This is information about a medication with the National Drug Code (NDC) 68382-582-01. The medication contains liothyronine sodium and each tablet is equivalent to a certain amount of liothyronine. The package insert has complete prescribing information including the usual dosage. The medication should be stored between 15°C-30°C and dispensed in child-resistant containers. It is important to keep this medication out of reach of children. The manufacturer is Cadia Healthcare Ltd in India, and the tablets are printed by Zydus Pharmaceuticals in the USA. This medication requires a prescription and it was manufactured specifically for distribution in Pennington, NJ 08534.*
Label (7f66fad6 E7f7 40aa A751 Bf6e681ac721 03)
This is a description of a medication called Liothyronine, with its associated National Drug Code (NDC) of 68382- 583-01. The text provides guidance on its usual dosage and proper storage instructions. The medication, containing 100 tablets, should be stored in a tightly sealed, child-resistant container between the temperatures of 15 and 30°C (59° to 86°F). There is a warning to use safety closures when dispensing the drug, unless healthcare providers or purchasers indicate otherwise. Additionally, the text mentions that Cadila Healthcare Ltd. in India is the manufacturer and the Zydus Pharmaceuticals (USA) Inc. is responsible for distribution. The text also offers caution to ensure that access to the drug is restricted from children.*
Label (7f66fad6 E7f7 40aa A751 Bf6e681ac721 04)
This is a medication package containing 100 tablets of Liothyronine Sodium. Each tablet contains 50mg of liothyronine sodium and it is manufactured by Cadia Healthcare Ltd in India and distributed by Zydus Pharmaceuticals in the USA. The package is child-resistant and should be stored between 15°C and 30°C. The usual dosage should be as indicated in the package insert for complete prescribing information. It is important to keep this drug out of the reach of children and to use safety closures when dispensing unless otherwise directed by the physician or purchaser.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
